Khaled Musallam/LinkedIn
Sep 2, 2026, 14:28
Khaled Musallam: The 5th MENA Congress for Rare Diseases Is Coming to Abu Dhabi
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
“Looking forward to the 5th MENA Congress for Rare Diseases, taking place 3–5 September in Abu Dhabi.
Pleased to contribute across three exciting areas – chairing the 2nd MENA Summit for Gene and Cell Therapy, chairing and speaking in the rare immune and blood disorders session, and chairing AI, research, and innovation in rare diseases.
Three days bringing together science, innovation, and collaboration to advance care for people living with rare diseases.”
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026